IκBβ-related proteins in normal and transformed colonic epithelial cells

Molecular Carcinogenesis

Volumn 29, Issue 1, 2000, Pages 25-36

  Watanabe, Yoh ^a   Haugen Strano, Astrid ^a   Umar, Asad ^a   Yamada, Kanae ^b   Hemmi, Hiromichi ^b   Kikuchi, Yoshinori ^a   Takano, Shoichi ^c   Shibata, Yoichiro ^a   Barrett, J Carl ^a   Kunkel, Thomas A ^a   Koi, Minoru ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c R and D Laboratories   (Japan)

Author keywords

Azoxymethane; Colon cancer; Colonic epithelial cells; I B ; Interleukin 1 ; NF B; Tumor necrosis factor

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; DNA BINDING PROTEIN; I KAPPA B; I KAPPA B BETA;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CELL LINE; CELL STRAIN HT29; COLON; METABOLISM;

ANIMALS; CELL LINE, TRANSFORMED; COLON; DNA-BINDING PROTEINS; EPITHELIAL CELLS; HT29 CELLS; HUMANS; I-KAPPA B PROTEINS; MICE;

EID: 0033623234     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2744(200009)29:1<25::AID-MC4>3.0.CO;2-A     Document Type: Article

References (48)

1. Function and activation of NF-κB in the immune system
2. NF-κB and Rel: Participants in a multiform transcriptional regulatory system
3. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
4. Suppression of TNF-≃-induced apoptosis by NF-κB
5. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
6. Inhibition of NF-κB activity induces apoptosis in murine hepatocytes
7. Inhibition of NF-κB/Rel induces apoptosis of murine B cells
8. Inhibition of nuclear factor kappa B (NF-κB) activity induces nerve growth factor-resistant apoptosis in PC12 cells
9. An essential role for NF-κB in preventing TNF-α-induced cell death
10. NF-κB prevents apoptosis and liver dysfunction during liver regeneration
11. Apoptosis: Activate NF-κB or die?
12. Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B
13. Induction of NF-kappa B DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts
14. NF-kappaB function in growth control: Regulation of cyclin D1 expression and G0/G1-to-S-phase transition
15. Constitutive activation of NF-κB causes resistance to apoptosis in cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermidiates
16. Mutations in the IκBα gene in Hodgkin's disease suggest a tumor suppressor role for IκBα
17. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer
18. Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells
19. NF-κB: A lesson in family values
20. The IκB protein: Members of a multifunctional family
21. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB
22. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway
23. IKK-1 and IKK-2: Cytokine-activated IkappaB kinases essential for NF-kappaB activation
24. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation
25. Tumor necrosis factor and interleukin-1 lead to phophorylation and loss of IκBα: Mechanism for NF-κB activation
26. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB
27. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination
28. NF-κB and REL proteins: Evolutionarily conserved mediators of immune responses
29. IκB-β regulates the persistent response in biphasic activation of NF-κB
30. Role of unphosphorylated, newly synthesized IκBβ in persistent activation of NF-κB
31. Distinct functional properties of IκBα and IκBβ
32. Alternative splicing variants of IκBβ establish differential NF-κB signal responsiveness in human cells
33. Nonsteroidal antiinflammatory drugs, short chain fatty acids and reactive oxygen metabolism in human colorectal cancer cells
34. TNF activates NF-κB by phosphatidyl choline-specific phospholipase C-induced 'acidic' sphingomyelin breakdown
35. The luminal short chain fatty acid butyrate modulates NF-κB activity in a human colonic epithelial cell line
36. Separation of pure populations of epithelial cells from rabbit distal colon
37. Characterization of ES cells deficient for the p105 precursor (NF-κB1): Role of p50 NLS
38. Altered expression of cyclin D1 and cyclin-dependent kinase 4 in AOM-induced mouse colon tumorigenesis
39. Evidence for altered IκBα degradation in human colonic epithelial cells
40. The NF-κB and IκB proteins: New discoveries and insights
41. Protein degradation or regulation, Ub the judge
42. NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress
43. Activation-dependent transcriptional regulation of the human Fas promoter requires NF-κB p50-p65 recruitment
44. Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression
45. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB
46. Down-regulation of NF-κB activity and NF-κB p65 subunit expression by ras and polyoma middle T oncogenes in human colonic Caco-2 cells
47. High-level expression of IκBβ in the surface epithelium of the colon: In vitro evidence for an immunomodulatory role
48. The role of protein stability in the cell cycle and cancer